Merit Medical Systems, Inc. (MMSI) fair value analysis

Nasdaq · Updated 2026-09-07

Merit Medical Systems, Inc. is a medical device company that designs, manufactures, and distributes cardiovascular and oncology medical devices. The company operates globally with manufacturing and distribution facilities across multiple continents serving hospitals, clinics, and healthcare providers worldwide.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, MMSI is trading at a 10–25% discount to estimated fair value.

MMSI currently ranks #35 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.

Last price: $85.53
Sector: Healthcare
12-month range: $62.01–$87.34

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: A
Momentum grade: A
Leverage: Moderate
Margin trend: Expanding
Revenue growth: Strong
RSI zone: Neutral
50/200-day trend: Uptrend
52-week position: The top quarter of its range
DCF cross-check: Overvalued

What our data shows for MMSI

Our model validated 17 trailing price-to-earnings windows for MMSI, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $62.01–$87.34.
The 14-day relative strength index sits at a neutral 55.
4 of the last 12 weekly snapshots showed positive price momentum.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for MMSI
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent MMSI news

TickrTrends' derived news-sentiment signal for MMSI is currently leaning positive, computed from recent coverage.

Merit Medical to Participate in Upcoming Investors Conferences in September (manilatimes.net, 2026-09-04)
TickrTrends take: Merit Medical Systems announced participation in investor conferences scheduled for September, which typically provide opportunities for management to discuss operational performance and strategic direction with institutional investors. Given TickrTrends' current assessment that MMSI trades as undervalued, such conference appearances may offer insight into whether management commentary addresses the factors contributing to the current valuation discount in the Healthcare sector. Investors focused on valuation metrics should monitor whether these conferences yield guidance or updates that could affect the company's fundamental outlook relative to its current market price.
Merit Medical Systems (MMSI) COO Neil Peterson Sells 7,500 Shares (gurufocus.com, 2026-08-26)
TickrTrends take: Merit Medical Systems operates in the Healthcare sector and is currently assessed as undervalued according to TickrTrends valuation analysis. The recent sale of 7,500 shares by Chief Operating Officer Neil Peterson represents an insider transaction that may warrant monitoring by valuation-focused investors, as insider selling activity can sometimes signal shifting confidence levels among company leadership. Given the current undervalued designation, observers should track whether additional insider transactions or changes in company fundamentals alter the valuation outlook.
Merit Medical Announces Global Operations Leadership Transition (manilatimes.net, 2026-08-19)
TickrTrends take: Merit Medical Systems announced a global operations leadership transition, which represents an organizational change that valuation-focused investors should monitor for potential impacts on operational efficiency and cost structure. Leadership transitions in the healthcare sector can affect execution timelines and capital deployment, both of which influence the company's ability to deliver on growth projections that support its current undervalued assessment. Investors tracking this development should remain attentive to how management communicates operational continuity and strategic priorities in upcoming earnings reports and guidance updates.

What people are saying

Follow the MMSI conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is MMSI stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), MMSI is trading at a 10–25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is MMSI's TickrTrends verdict?

MMSI's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does MMSI compare to other Healthcare stocks?

MMSI ranks #35 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is MMSI overbought or oversold?

MMSI's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

MMSI vs ABT · MMSI vs CI · MMSI vs GEHC · MMSI vs INCY · MMSI vs INDV